Acura Pharmaceuticals Gross Profit 2010-2021 | ACUR

Acura Pharmaceuticals gross profit from 2010 to 2021. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Acura Pharmaceuticals Annual Gross Profit
(Millions of US $)
2021 $2
2020 $4
2019 $3
2018 $0
2017 $3
2016 $4
2015 $8
2014 $1
2013 $0
2012 $0
2011 $20
2010 $3
2009 $4
Acura Pharmaceuticals Quarterly Gross Profit
(Millions of US $)
2021-12-31 $0
2021-09-30 $0
2021-06-30 $1
2021-03-31 $1
2020-12-31 $1
2020-09-30 $0
2020-06-30 $1
2020-03-31 $1
2019-12-31 $1
2019-09-30 $1
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $3
2016-12-31 $4
2016-09-30 $0
2016-06-30 $0
2016-03-31 $0
2015-12-31 $3
2015-09-30 $0
2015-06-30 $0
2015-03-31 $5
2014-12-31 $0
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31 $0
2011-09-30
2011-06-30 $20
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $1
2010-03-31 $2
2009-12-31 $1
2009-09-30 $1
2009-06-30 $1
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.001B $0.000B
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.207B 6.94
Dr Reddy's Laboratories (RDY) India $12.054B 21.88
BridgeBio Pharma (BBIO) United States $6.426B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.872B 15.19
Bausch Health Cos (BHC) Canada $1.692B 1.25
Amphastar Pharmaceuticals (AMPH) United States $1.181B 7.87
Taysha Gene Therapies (TSHA) United States $0.580B 0.00
Personalis (PSNL) United States $0.437B 0.00
Assembly Biosciences (ASMB) United States $0.103B 0.00
Sol-Gel Technologies (SLGL) Israel $0.021B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00